About
Eltoukhy received his Ph.D., M.S. and B.S. degrees in electrical engineering from Stanford University, according to the proxy statement. He co-founded Avantome in 2007 to commercialize semiconductor DNA sequencing, and Illumina acquired it in 2008. He then held roles at Illumina, including senior director of advanced technology research, until December 2012. Related pages on Whoo include Jacob Thaysen, the chief executive officer of Illumina, and Marc Casper of Thermo Fisher Scientific.
Whoo compiled this page from public sources: Guardant Health third-quarter 2026 results release (SEC), Guardant Health 2026 proxy statement (SEC), Wikipedia. It is not affiliated with or endorsed by Helmy Eltoukhy. Are you Helmy Eltoukhy? Claim this page, or write to [email protected] to correct or remove it. Last updated: 2026-11-18. Photo: Perepeteia, CC BY-SA 4.0, via Wikimedia Commons.
Want a page like this? Create yours from your résumé.
Experience
Co-founder, Co-CEO and Chairperson — Guardant Health
January 2013 – Present
- Served as CEO and a director from January 2013
- Became co-CEO and chairperson on August 5, 2021
- Developed chemistries, hardware and informatics for genetic analysis systems
- Worked to commercialize semiconductor DNA sequencing; Illumina acquired the company in August 2008
Senior Director of Advanced Technology Research and other roles — Illumina
August 2008 – December 2012
Co-founder and Chief Executive Officer — Avantome
June 2007 – August 2008
Post-doctoral Fellow — Stanford Genome Technology Center
2006